LOADING
Tag: Pharma
LEO Pharma launches Talk to the Hand campaign to raise awareness of the impact of chronic hand eczema – PharmaLive
October 30, 2024
LEO Pharma launches Talk to the Hand campaign to raise awareness of the impact of chronic hand eczema PharmaLive Source link
chat_bubble0 Comment
visibility170 Views
LEO Pharma Presents Prevalence, Severity, and Treatment CHECK Data for Chronic Hand Eczema – Dermatology Times
September 6, 2024
LEO Pharma Presents Prevalence, Severity, and Treatment CHECK Data for Chronic Hand Eczema Dermatology Times Source link
chat_bubble0 Comment
visibility173 Views
Leo Pharma prepares to come for the topical JAK market as Incyte’s Opzelura cream launch cools off
May 4, 2024
Watch out, Incyte. Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market, currently inhibited by Incyte’s approved Opzelura. With several positive studies in hand, including a recent phase 3 trial pitting the candidate against the current standard-of-care, Leo says its delgocitinib has growth driver potential. Now, the drugmaker […]
chat_bubble0 Comment
visibility193 Views